G9650 – Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi

Long description

Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi

Short description

Doc pt no ther chg or contra

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2016

Last change

January 1, 2017 – No change

Termination date

December 31, 2016

Nearby G codes

• G9642 – Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)
• G9643 – Elective surgery
• G9644 – Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure
• G9645 – Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure
• G9646 – Patients with 90 day mrs score of 0 to 2
• G9647 – Patients in whom mrs score could not be obtained at 90 day follow-up
• G9648 – Patients with 90 day mrs score greater than 2
• G9649 – Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
• G9651 – Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented
• G9652 – Patient has been treated with a systemic or biologic medication for psoriasis for at least six months
• G9653 – Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months
• G9654 – Monitored anesthesia care (mac)
• G9655 – A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used
• G9656 – Patient transferred directly from anesthetizing location to pacu or other non-icu location
• G9657 – Transfer of care during an anesthetic or to the intensive care unit
• G9658 – A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used